The Incidence of Type 1 Diabetes in the Age Group 0–39 Years Has Not Increased in Antwerp (Belgium) Between 1989 and 2000
Evidence for earlier disease manifestation
- Ilse Weets, MD1,
- Ivo H. De Leeuw, MD, PHD2,
- Marc V.L. Du Caju, MD, PHD2,
- Raoul Rooman, MD2,
- Bart Keymeulen, MD, PHD1,
- Chantal Mathieu, MD, PHD3,
- Raoul Rottiers, MD4,
- Jean-Claude Daubresse, MD5,
- Danielle Rocour-Brumioul, MD6,
- Daniel G. Pipeleers, MD, PHD1,
- Frans K. Gorus, MD, PHD1 and
- The Belgian Diabetes Registry7
- 1Diabetes Research Center, Free University, Brussels, Belgium
- 2Departments of Endocrinology and Pediatrics, University of Antwerp, Antwerp, Belgium
- 3Department of Endocrinology, Catholic University, Leuven, Belgium
- 4Department of Endocrinology, University of Ghent, Ghent, Belgium
- 5Department of Endocrinology, Civil Hospital of Charleroi, Charleroi, Belgium
- 6Department of Pediatric Endocrinology, CHR la Citadelle, Liège, Belgium
- 7Belgian Diabetes Registry, Brussels, Belgium
Abstract
OBJECTIVE—A worldwide increase in the incidence of childhood type 1 diabetes has been observed. Because in various countries the majority of new type 1 diabetic patients are diagnosed in adulthood, we investigated whether the rising incidence of this disorder in children reflects a global increase in the incidence of diabetes or a shift toward earlier clinical presentation.
RESEARCH DESIGN AND METHODS—The incidence of type 1 diabetes presenting before age 40 years was prospectively measured in the Antwerp district over a 12-year period (1989–2000). The completeness of ascertainment was evaluated by the capture-recapture method. Trends in incidence during the study period were analyzed by Poisson regression.
RESULTS—The incidence of type 1 diabetes diagnosed before age 40 years remained constant over the 12-year period, averaging 9.9 cases per 100,000 individuals per year. The incidence was similar in both sexes under age 15 years, but a marked male excess was noted for adult-onset disease, in particular after age 20 years, resulting in a male-to-female ratio of 0.9 under age 15 years vs. 1.6 thereafter (P = 0.001). During the 12-year observation period, there was a significant tendency toward increasing incidence under age 15 years at the expense of a decreasing incidence between ages 15 and 40 years (P = 0.025). The annual increase in incidence averaged 1.8% under age 15 years and 5.0% under age 5 years (P = 0.06).
CONCLUSIONS—Our results indicate that in Belgium, the increasing incidence of childhood type 1 diabetes—especially for children under age 5 years—is not attributable to a global increase in disease incidence, but rather to earlier clinical manifestation. The results suggest that an environmental factor may preferentially accelerate the subclinical disease process in young diabetes-prone subjects.
- BDR, Belgian Diabetes Registry
- DIAMOND, DIAbetes MONDiale study
- EURODIAB, EUROpe and DIABetes study
- IAA, insulin autoantibody
- IDA, Insulin-dependent Diabetes in young Adults study
- GADA, glutamate decarboxylase antibody
- RR, risk ratio
Footnotes
-
Address correspondence and reprint requests to Frans K. Gorus, MD, PhD, Diabetes Research Center, Vrije Universiteit Brussel, Laarbeeklaan 103, B-1090 Brussels, Belgium. E-mail: frans.gorus{at}az.vub.ac.be.
Received for publication 31 October 2001 and accepted in revised form 29 January 2002.
A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.














